The goal of Siteman Cancer Center (SCC) Administration is to provide cutting edge research support for investigators, in order to facilitate development and growth of collaborative grants, clinical trials, and publications. SCC Administration supports the 270 SCC members, 8 research programs, 13 cores (11 full and two developing), and research working groups by providing: Administrative oversight of research programs and shared resources Administration of Research Development Award Program (seed grant mechanism) Administration of the SCC membership process Coordination of research seminars, workshops, and retreats Leadership or assistance in developing collaborations between investigators for new research initiatives Planning, coordination, and execution of multi-project research grants (e.g., SPOREs, PPGs) Targeted communication of cancer-related funding opportunities to SCC members Assistance for the SCC Director in recruitment of new faculty Development and management of computer databases and other information systems tools Fiscal management and consultation Space and equipment management Administrative leadership ofthe SCC strategic planning process Management ofthe Cancer Biology Pathway (doctoral training program) within the Division of Biology and Biomedical Sciences Administration of the SCC Summer Opportunities program SCC World Wide Web page development and maintenance

Public Health Relevance

Siteman Cancer Center Administration manages and facilitates the research of the only NCI Comprehensive Cancer Center in the state of Missouri and southern Illinois, with the goal to foster cutting edge, transdisciplinary science to reduce and ultimately eliminate the threat and impact of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-12
Application #
8520199
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
12
Fiscal Year
2013
Total Cost
$191,433
Indirect Cost
$53,165
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Zuiani, Adam; Chen, Kevin; Schwarz, Megan C et al. (2016) A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I. J Virol 90:10499-10512
Abboud, Ramzi; Keller, Jesse; Slade, Michael et al. (2016) Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated. Biol Blood Marrow Transplant 22:1851-60
Johnson, Kimberly J; Zoellner, Nancy L; Gutmann, David H (2016) Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1. Cancer Epidemiol 42:53-9
Brownson, Ross C; Dodson, Elizabeth A; Kerner, Jon F et al. (2016) Framing research for state policymakers who place a priority on cancer. Cancer Causes Control 27:1035-41
Chou, Chun; Verbaro, Daniel J; Tonc, Elena et al. (2016) The Transcription Factor AP4 Mediates Resolution of Chronic Viral Infection through Amplification of Germinal Center B Cell Responses. Immunity 45:570-82
Durai, Vivek; Murphy, Kenneth M (2016) Functions of Murine Dendritic Cells. Immunity 45:719-736
Beeman, Scott C; Shui, Ying-Bo; Perez-Torres, Carlos J et al. (2016) O2 -sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models. Magn Reson Med 75:2442-7
Mertins, Philipp; Mani, D R; Ruggles, Kelly V et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534:55-62
Niu, Haixia; Hadwiger, Gayla; Fujiwara, Hideji et al. (2016) Pathways of retinoid synthesis in mouse macrophages and bone marrow cells. J Leukoc Biol 99:797-810
Fehniger, Todd A; Cooper, Megan A (2016) Harnessing NK Cell Memory for Cancer Immunotherapy. Trends Immunol 37:877-888

Showing the most recent 10 out of 947 publications